(TNON) Tenon Medical, Inc. Business Model Canvas Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(TNON) Tenon Medical, Inc. Complete Analysis Pack
Tenon Medical Business Model Canvas: Strategy in One View
Explore Tenon Medical, Inc.’s Business Model Canvas to see how the company creates value in the orthopedic implant space, reaches customers, and supports growth. This concise, company-specific snapshot highlights the key levers behind its strategy. Download the full canvas to get the complete breakdown in Word and Excel.
Partnerships
Orthopedic and spine surgeons
Orthopedic and spine surgeons are Tenon Medical’s core SIJ fixation and fusion partners; their technique validation shapes OR workflow and product choice. Their feedback feeds training and product updates, which matters as Tenon scales a procedure-led model in a market where U.S. spinal fusion cases remain in the hundreds of thousands each year.
Hospitals and ambulatory surgery centers
Hospitals and ambulatory surgery centers are Tenon Medical, Inc.'s main SIJ fusion procedure sites, and their purchasing and credentialing rules can slow or speed adoption. In the U.S., more than 5,000 hospitals and about 6,300 ASCs control implant approval, inventory placement, and surgeon access, so each site win can materially expand procedure volume.
Independent distributors and sales reps
Independent distributors and sales reps extend Tenon Medical, Inc. reach across 50 U.S. states and Puerto Rico, adding local account coverage, case logistics, and surgeon access. For a focused medtech company, this field network helps move a small commercial team into 51 markets without building a full in-house sales force.
Contract manufacturers and suppliers
Tenon Medical, Inc. relies on contract manufacturers and suppliers to make implants, instruments, and sterile packaging, so this partnership layer directly supports quality, scale, and supply continuity. It also covers component sourcing and sterilization services, which matter when a small medtech firm must keep production steady without tying up heavy in-house capex.
- Implants and instruments are externally made
- Sterilization and packaging sit here
- Supply continuity protects delivery
This setup helps Tenon Medical keep fixed costs lower while it scales output and meets hospital demand.
Regulatory and clinical consultants
Regulatory and clinical consultants help Tenon Medical, Inc. lower launch risk by guiding FDA, quality, reimbursement, and clinical study work. For implantable spinal and SIJ devices, they also keep evidence generation tight and compliance on track, which matters because a missed step can slow clearance, coding, or adoption.
- Reduce FDA and quality risk
- Support reimbursement and study data
- Help speed commercialization
Tenon’s Growth Hinges on Key Surgical and Hospital Partnerships
Tenon Medical, Inc. depends on surgeons, hospitals, ASCs, distributors, contract makers, and regulatory consultants to sell, place, and support its SIJ fixation system. These ties matter because more than 5,000 U.S. hospitals and about 6,300 ASCs control access, while Tenon’s field network reaches 50 states and Puerto Rico.
| Partner | Why it matters |
|---|---|
| Surgeons | Drive use and training |
| Hospitals/ASCs | Gate procedure access |
| Manufacturers | Support supply continuity |
What is included in the product
Detailed Word Document
A concise, real-world Business Model Canvas capturing Tenon Medical’s orthopedic device strategy, customers, channels, and value creation.
Customizable Excel Spreadsheet
Quickly shows how Tenon Medical, Inc. relieves key pain points with a clear, one-page business model snapshot.
Reference Sources
Provides a clear source trail for Tenon Medical, Inc., strengthening credibility and speeding investor due diligence.
Activities
SIJ implant system design
Tenon Medical designs SIJ implant and instrument solutions for sacroiliac joint fixation and fusion, with engineering centered on procedural fit, implant performance, and surgical usability. Its named platform, the CATAMARAN SIJ Fusion System, anchors this activity and supports the company’s focus on improving the SI joint fusion workflow.
Regulatory and quality management
Regulatory and quality management is a core activity for Tenon Medical, Inc. because U.S. medical device firms must keep design controls and quality systems ready for FDA oversight; the new Quality Management System Regulation (QMSR) starts Feb. 2, 2026, and aligns with ISO 13485. Strong controls help keep Tenon Medical’s products consistent and support market access in the United States and Puerto Rico.
Clinical education and surgeon training
Tenon Medical’s adoption hinges on surgeon familiarity, so clinical education, case support, and technique training are core activities that cut learning-curve friction and build confidence in the instrument set. In its latest filings, the company kept investing in these support functions because even small procedure volumes can depend on hands-on surgeon onboarding and repeat case success.
Commercial sales execution
Tenon Medical, Inc. must convert clinical interest into procedure volume by selling into hospitals, ASCs, and physician-led accounts, so field reps and distributors need tight account coverage and fast follow-up. In a niche orthopedic market, penetration depth matters more than broad reach, because each new account can drive repeat Cassi use and build procedure cadence.
- Target hospitals, ASCs, and physicians
- Use reps to drive procedure volume
- Win coverage in key accounts
Supply chain and inventory management
In Tenon Medical, Inc.'s implant model, instruments, trays, and procedure-ready kits must be stocked and replenished daily so cases can ship on time. Tight inventory control keeps finished goods available, lowers missed-case risk, and supports customer satisfaction.
- Keep kits case-ready
- Replenish stock fast
- Protect case coverage
Tenon Medical: Building Adoption for SIJ Fusion
Tenon Medical, Inc. focuses on SIJ implant design, FDA-ready quality systems, and surgeon training that supports adoption of the CATAMARAN SIJ Fusion System. It also runs account coverage, case support, and inventory control to keep hospitals, ASCs, and physician-led sites supplied and procedure-ready.
| Key activity | Why it matters |
|---|---|
| Design and engineering | CATAMARAN SIJ Fusion System |
| Quality and regulatory | QMSR starts Feb. 2, 2026 |
| Training and case support | Drives surgeon adoption |
Delivered as Displayed
Business Model Canvas
This Tenon Medical, Inc. Business Model Canvas preview is the same document you’ll receive after purchase. It’s not a sample or mockup—what you see here is a direct view of the final file. Once purchased, you’ll get the complete, fully formatted version ready to download, edit, and use right away.
Resources
CATAMARAN SIJ Fusion System
CATAMARAN SIJ Fusion System is Tenon Medical, Inc.'s core product asset and main commercial offering. It combines specialized instruments and implants for sacroiliac joint (SIJ) preparation and fusion, and it is the company's key source of product differentiation.
Product IP and engineering know-how
Product IP and engineering know-how are core intangible assets for Tenon Medical, Inc.; its SIJ fixation and fusion design expertise supports product development, defends differentiation, and can feed future line extensions. That know-how also drives refinements in instrumentation and implant geometry, which matter in a market where device performance and surgeon workflow can decide adoption.
Regulatory and quality infrastructure
Tenon Medical, Inc. needs strong regulatory and quality infrastructure: compliance systems, SOPs, and device history records support release, traceability, and market access. The FDA’s Quality Management System Regulation starts Feb. 2, 2026 and aligns more closely with ISO 13485, so these controls are now a core resource for keeping provider and regulator trust.
Commercial field team and distributors
Tenon Medical, Inc.’s commercial field team and distributors are a core operating asset: in surgical devices, direct sales coverage drives surgeon access, case support, and local account management. This matters even more for a focused product line, where each rep and distributor must help place cases and keep hospitals engaged.
- Drives surgeon access
- Supports live cases
- Manages local accounts
- Fits narrow product lines
Headquarters in Los Gatos, California
Tenon Medical, Inc.'s headquarters in Los Gatos, California anchors management, operations, and cross-team coordination. It supports finance, product planning, and commercialization for its specialized sacroiliac joint device portfolio, with centralized leadership helping the Company manage a focused, FDA-regulated product set from one U.S. base.
- Central hub for leadership and oversight
- Supports finance, planning, commercialization
- Helps manage a specialized device portfolio
CATAMARAN SIJ Drives Tenon’s Growth
Tenon Medical, Inc.’s key resources are its CATAMARAN SIJ Fusion System, SIJ IP, and FDA-ready quality controls. Its sales force and distributor ties turn that asset base into surgeon access and case support, while the Los Gatos hub keeps product, finance, and commercialization aligned.
| Resource | Why it matters |
|---|---|
| CATAMARAN SIJ | Core revenue asset |
| QMS | QSR rule starts 2026-02-02 |
Value Propositions
SIJ fixation and fusion focus
Tenon Medical, Inc. stays focused on sacroiliac joint fixation and fusion, so its devices are built for one procedure class instead of a broad orthopedic mix. That narrow focus can improve product fit for SIJ surgeons and gives buyers a specialized option versus larger portfolios that spread R&D and sales across many indications.
Specialized instruments and implants
Tenon Medical, Inc.'s CATAMARAN system pairs procedure-specific instruments with implants, so surgeons use one purpose-built set instead of disconnected parts. That integration can simplify preparation, placement, and fusion workflow in sacroiliac joint procedures, where fewer handoffs can mean a smoother case.
Engineered for secure fusion
Tenon Medical, Inc. is engineered for secure SI joint fusion, with the core value in helping prepare the joint and deliver stable fixation during surgery. That focus matches the main clinical need: reliable stability and fusion performance for an anatomically complex joint, where poor fixation can raise revision risk.
Potential for better patient outcomes
Tenon Medical positions its SIJ technology around better patient outcomes: more reliable fixation, a more consistent procedure, and less room for variability. That matters because SI joint pain drives up to 15% of chronic low back pain cases, so providers adopt tools that can improve predictability and results.
- More reliable fixation
- More consistent surgery
- Outcome gains drive adoption
U.S. and Puerto Rico availability
Tenon Medical, Inc. sells its system across the United States and Puerto Rico, giving it a defined commercial footprint in current markets. That regional reach supports local servicing and helps the company build sales coverage where spinal care demand is already established.
- U.S. and Puerto Rico distribution
- Supports service and sales coverage
- Signals active market footprint
Tenon Medical: Focused SI Joint Fusion With U.S. Sales Support
Tenon Medical, Inc. offers a focused SI joint fusion value prop: a procedure-specific CATAMARAN system designed to simplify fixation and improve workflow in a niche where precision matters. In fiscal 2025, the company remained U.S.-focused, which supports direct surgeon coverage and hands-on service.
| Value prop | Why it matters |
|---|---|
| SIJ focus | Specialized fit |
| Integrated system | Simpler workflow |
| U.S. footprint | Local sales support |
Customer Relationships
Direct clinical support
Field support helps surgeons during setup and procedures, which matters in implantable devices where technique can drive adoption and repeat use. Tenon Medical, Inc. had $0.5 million in revenue in Q1 2025, so direct clinical support can be a key lever for conversion and retention.
Surgeon education programs
Surgeon education is a recurring relationship tool for Tenon Medical, Inc.: each program teaches 3 core areas—indications, technique, and instrumentation handling—so users can adopt the Catamaran System safely and consistently. It also supports repeat engagement after launch, which matters because in 2025 Tenon Medical still relied on surgeon adoption and training to drive use.
Account-based selling
Tenon Medical, Inc. uses account-based selling because hospitals and ASCs need tailored support, not a one-size-fits-all pitch. The buying path is consultative and usually involves 3 groups at once: surgeons, supply chain teams, and administrators, so each account needs coordinated education, access, and follow-up.
Distributor-managed engagement
Tenon Medical, Inc. leans on local distributors to keep an active presence in territories and customer accounts without a large direct sales team. That model is built for coverage, and for a small medtech company it helps extend reach while keeping fixed selling costs lower.
- Local reps keep accounts warm.
- Coverage grows without heavy headcount.
Post-sale technical assistance
Post-sale technical assistance is critical for Tenon Medical, Inc. because device customers need fast help with inventory, trays, and case readiness to avoid procedure delays. Strong support cuts disruption, protects surgeon and hospital relationships, and helps drive repeat orders and product loyalty.
- Fast support keeps cases on schedule.
- Tray issues can disrupt procedures.
- Better service improves retention.
Surgeon Training and Support Drive Tenon’s Repeat Use
Tenon Medical, Inc. keeps customer ties tight through surgeon training, field support, and account-based selling, since each hospital or ASC needs setup help, case readiness, and follow-up. In Q1 2025, revenue was $0.5 million, so retaining trained surgeons and keeping cases on schedule is central to repeat use.
| Channel | Role | 2025 data |
|---|---|---|
| Field support | Procedure help | $0.5m Q1 revenue |
| Surgeon training | Adoption | 3 focus areas |
Channels
Direct hospital sales
Hospitals are the main buying gate for surgical implants, and direct hospital sales let Tenon Medical, Inc. manage specs, contracting, and product placement at the point of care. In the U.S., more than 6,000 hospitals drive these purchasing decisions, making this channel central for specialty orthopedic devices.
Ambulatory surgery center access
Ambulatory surgery centers (ASCs) are a key orthopedic site of care, with about 6,300 Medicare-certified ASCs in the U.S. Channel access depends on surgeon preference and OR readiness, so Tenon Medical, Inc. has to make implant delivery and case support fast, reliable, and low-friction.
Distributor network
Tenon Medical, Inc. uses distribution partners to add local case support and reach accounts across all 50 U.S. states plus Puerto Rico, which gives the Company broad coverage without a large direct sales force. For a focused medical device model, this channel can scale access fast while keeping fixed selling costs lower than a fully direct field team.
Field clinical support
Tenon Medical, Inc. uses field clinical support to put sales and clinical specialists in the room for case setup and procedure guidance, so the product fits the workflow faster and users get help at the point of care. This channel is important in adoption because it lowers setup friction and shortens the path from first use to routine use.
- Specialists support case setup.
- Bridges product and procedure.
- Improves adoption and user comfort.
Professional conferences and education
Professional conferences and surgeon education events help Tenon Medical, Inc. build awareness and show technique and product differences live. In medtech, peer learning often drives conversion, so each trained surgeon can matter more than broad ads, especially for a launch-stage Company with limited procedure volume.
- Builds awareness at industry meetings
- Shows technique and differentiation
- Peer learning supports conversion
Tenon Medical’s Direct-to-Point-of-Care Channel Strategy
Tenon Medical, Inc. sells mainly through direct hospital and ASC engagement, backed by distribution partners and field clinical support. With more than 6,000 U.S. hospitals and about 6,300 Medicare-certified ASCs, the Channel mix is built to reach surgeons at the point of care and speed adoption.
| Channel | Role | Data point |
|---|---|---|
| Hospitals | Primary buying gate | 6,000+ U.S. hospitals |
| ASCs | Fast-growing site of care | ~6,300 Medicare-certified ASCs |
| Distributors | Local reach | 50 states + Puerto Rico |
Customer Segments
Orthopedic surgeons
Orthopedic surgeons are Tenon Medical, Inc.’s core users for SIJ fixation and fusion products. They judge the technique, instrumentation, and clinical utility case by case, and their preference can decide whether a product gets adopted in practice.
That makes surgeon education and hands-on support critical, since even a small shift in surgeon choice can affect procedure volume and repeat use across a clinic or hospital network.
Spine surgeons
Spine surgeons are key procedural decision makers for sacroiliac joint (SIJ) care, especially for patients with low back or pelvic pain that may account for up to 15%-30% of chronic low back pain cases. Tenon Medical, Inc.'s direct posterior SIJ system fits their practice because these surgeons already manage complex spine and pelvic pain patients and need an implant approach that can be used in the 75+ million U.S. adults living with chronic back pain.
Hospitals
Hospitals are institutional buyers and procedure sites for Tenon Medical, Inc. They judge product availability, pricing, and clinical support, and access often runs through supply chain teams and clinical committees before use is approved.
Ambulatory surgery centers
Ambulatory surgery centers are a fast-growing outpatient channel, with more than 6,000 Medicare-certified ASCs in the U.S. They buy on speed: efficient workflows, reliable instrumentation, and case-ready support matter because turnover time and product fit directly affect daily case volume and margins for a lean site.
- Over 6,000 Medicare-certified ASCs
- Fast turnover is a buying priority
- Case-ready support reduces delays
U.S. and Puerto Rico provider accounts
Tenon Medical, Inc. serves provider accounts in the U.S. and Puerto Rico, so its customer base is regional, not global. That narrow footprint points to a geographically defined market focus, with sales tied to 2 territories rather than a worldwide channel.
- U.S. and Puerto Rico only
- Regional provider base
- Geographically defined focus
Tenon Medical Targets a Large U.S. Chronic Back Pain Market
Tenon Medical, Inc. targets spine and orthopedic surgeons, plus hospitals and ambulatory surgery centers, with U.S. and Puerto Rico provider accounts. Demand is tied to the 75+ million U.S. adults with chronic back pain, and SIJ pain may represent 15%-30% of chronic low back pain cases.
| Customer segment | Need |
|---|---|
| Surgeons | Technique, outcomes |
| Hospitals/ASCs | Speed, support |
| Market | U.S. and Puerto Rico |
Cost Structure
Research and development
Tenon Medical, Inc. keeps research and development as a core fixed cost because new implants and instruments need design work, prototyping, and testing. In its latest reported fiscal year, R&D stayed a key cash use for a focused medtech model, where each new product cycle can require several design iterations before launch.
Manufacturing and supply costs
Tenon Medical, Inc. ties manufacturing and supply costs to implants, instruments, packaging, and sterilization-related services, all of which feed cost of goods sold. Quality-controlled production is non-negotiable for patient safety and product consistency, and any supplier slip can hit margins fast in a low-volume medical device model.
Regulatory and quality expenses
Tenon Medical, Inc. must fund FDA and quality-system work year-round: documentation, audits, supplier checks, complaint handling, and CAPA (corrective and preventive action). These costs are non-discretionary because they keep market access open and lower recall, warning-letter, and shipment-delay risk.
Sales, marketing, and clinical support
Tenon Medical, Inc. must fund field sales, surgeon training, and in-case support to win adoption, and these costs are heavy in surgical devices. In medtech, sales and marketing often absorb 15%-25% of revenue, because case support drives conversion, repeat use, and account growth.
- Field reps drive surgeon conversion.
- Training cuts adoption friction.
- Case support protects procedure success.
General and administrative overhead
General and administrative overhead for Tenon Medical, Inc. covers headquarters operations, finance, legal, and public-company costs, and it funds corporate governance plus day-to-day management. For a Los Gatos-based medical-device company, keeping this overhead centralized matters because it supports a lean structure while still meeting SEC, audit, and board reporting demands.
- HQ, finance, and legal support core control.
- Public-company costs add recurring fixed expense.
- Centralized overhead helps keep management tight.
Costly Growth: Tenon’s R&D and Sales Burn Margin
Tenon Medical, Inc. keeps cost heavy in R&D, FDA/quality work, and field sales support; these are the main fixed and semi-fixed drains in a low-volume implant model. Manufacturing, packaging, sterilization, and public-company overhead add more pressure, so margin depends on tight control and slow, disciplined scaling.
| Cost | Driver |
|---|---|
| R&D | Design, testing |
| COGS | Implants, sterilization |
| Sales | Rep support, training |
Revenue Streams
Implant product sales
Tenon Medical, Inc. makes most of its revenue from SIJ fusion implant sales, and that stream rises or falls with procedure volume and how many accounts are actively using the system. Implant sales are the core commercial engine, so more surgeon adoption and repeat use should translate into higher revenue.
Instrument and system sales
Tenon Medical's CATAMARAN system pairs implants with specialized instruments, so revenue comes from both system placement and related tool sales. The instruments are not optional add-ons; they are part of the procedure workflow, which helps make each case a second revenue point beyond implant sales.
Replenishment orders
Replenishment orders from hospitals, ASCs, and distributors can create recurring revenue for Tenon Medical, Inc. once a system is adopted. In a procedure-based model, consumables and replacement parts often follow the initial sale, so repeat demand can lift revenue per installed site.
Distributor-driven sales
Tenon Medical, Inc. earns distributor-driven sales by using territory coverage across the United States and Puerto Rico, giving it reach into 2 linked markets through one channel. Distributor relationships can speed account access and order flow, which helps expand sales without building a large direct force.
- US and Puerto Rico coverage
- Faster account access
- Broader sales reach
- Order flow via distributors
Procedure-linked account growth
Procedure-linked account growth means Tenon Medical, Inc. can sell more implants inside the same hospital or surgeon account as SIJ fusion case volume rises; revenue then tracks utilization and surgeon confidence, so each added case can lift repeat ordering. Higher volume also usually lowers per-case commercial cost, because the same sales coverage supports more procedures.
- More SIJ fusion cases, more repeat orders
- Revenue scales with surgeon adoption
- Higher volume improves commercial efficiency
Tenon Medical Revenue: Implants, Instruments, and Distributor Reach
Tenon Medical, Inc. mainly earns revenue from CATAMARAN SIJ fusion implant sales, plus the related instruments used in each procedure. Revenue also depends on distributor coverage in the U.S. and Puerto Rico, so more surgeon adoption and repeat cases can lift orders and recurring replenishment demand.
| Stream | Driver |
|---|---|
| Implants | Procedure volume |
| Instruments | Each case |
| Distributors | Account reach |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.